Tumor antigen-specific CD8+ T-cells proliferate and differentiate into cytotoxic effector T-cells that migrate from the LNs to the tumor sites (primary tumor and nonirradiated tumor metastases) in order to exercise their effect of killing tumor cells. The gene discussed is CD8A; the disease is neoplasm.